ALK-abello A/S (XETR:4AJ0) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Edward Jordan Other companies: DBV Technologies SA (EVP and head of Commercial Operations North America · Since at least Dec 1, 2025); Teva Pharmaceutical Industries Limited (EVP and head of Commercial Operations North America · Since at least Dec 1, 2025) | Executive Vice President, Commercial Operations North America · Since at least Dec 1, 2025 |
| Alan Main | Board member · Since at least Nov 5, 2026 |
| Anders Hedegaard | Chair of the Board · Since at least Nov 5, 2026 |
| Bertil Lindmark | Board member · Since at least Nov 5, 2026 |
| Christian G. Houghton | Executive Vice President, Product Supply · Since at least Nov 5, 2026 |
| Claus Steensen Sølje | Executive Vice President & CFO · Since at least Apr 28, 2026 |
| Flora Beiche-Scholz | Executive Vice President, Commercial Operations Europe · Since at least Sep 4, 2025 |
| Gitte Aabo | Board member · Since at least Nov 5, 2026 |
| Jacob Glenting | EVP Global Research & Development · Since at least Nov 5, 2026 |
| Jan Engel | Senior Vice President, Global Quality · Since at least Nov 5, 2026 |
| Jesper Høiland | Independent Director · Since at least Nov 4, 2026 |
| Johan Smedsrud | Board member · Since at least Nov 5, 2026 |
| Katja Barnkob | Board Member · Since at least Nov 5, 2026 |
| Lars Holmqvist | Board member · Since at least Nov 5, 2026 |
| Lene Skole | Vice Chair · Since at least Nov 5, 2026 |
| Lika Thiesen | Executive Vice President, Global People & Organisation · Since at least Nov 5, 2026 |
| Lise Lund Mærkedahl | Board member · Since at least Nov 5, 2026 |
| Nanna Carlson | Board Member · Since at least Nov 5, 2026 |
| Peter Halling | President & CEO · Since at least Apr 28, 2026 |
| Tina Abild Olesen | EVP Corporate, Portfolio and Product Strategy · Since at least Nov 4, 2026 |